The exact mechanism is not entirely understood, and though many pro-inflammatory cytokines play similar roles in IMIDs, the responses to treatments may differ entirely: the IL-17 blockade is beneficial in psoriasis but rather harmful in IBD [228,229]. Here, IL17A is linked to psoriasis.